Biomed Nattokinase NSK-SD

Consult a health care practitioner if you have a cardiovascular, kidney, or liver disorder, or if you are taking any medications. In addition, euglobulin fibrinolytic activity (EFA; lysis area on a fibrin plate) was increased significantly up to 12 hours following administration.NSK-SD is a superior form of NattokinaseHighest potency available > 20,000 F.U./gram on the marketVitamin K2 - freeNon-GMO, vegan and non-irradiatedRecognized by the JHFA (Japan Health and Nutrition Food Authorization) and the JNKA (Japan Nattokinase Association) as authentic NattokinaseFeatures:Dissolves fibrin clots (blood clots)Improved blood circulationCardiovascular & Arterial healthDosage: 1 capsule once daily    Active ingredients: Each capsule contains:Nattokinase 100 mgNon-active ingredients: Cellulose, maltodextrin, hydroxypropyl methylcellulase, magnesium stearate.Caution: Contra-Indications: Do not use if you are pregnant or breastfeeding, if you are taking health products that affect blood coagulation, or if you have a bleeding disorder. Nattokinase has been shown to degrade fibrin clots both in clot lysis assays comparable to plasmin and by affecting plasminogen activator inhibitor 1 (PAI-1), which is the primary inhibitor of tissue-type plasminogen activator (t-PA).Human clinical studies have demonstrated the ability of nattokinase to decrease euglobin (clot) lysis time (ELT) up to 8 hours after oral intake of a dose of natto estimated at 6,000 fibrin degradation units (FU). Stop using this product 7 days before any scheduled surgery, or immediately if you have unscheduled

Cardiovascular Support

Biomed Nattokinase NSK-SD